Livoa LogoLivoa
[No AD]
[Cognitively Normal]
[Preclinical AD (~20 years)]


• Compromised neuronal integrity & synaptic function

• Tau tangles

• CSF tau changes

• Amyloid plaques

• Reduced amyloid clearance

• Hippocampal volume changes

[Transition Phase]


• Initial cognitive impairment begins

[Symptomatic AD (~7–12 years)]


• Memory loss

• Metabolism changes

• Depression

• Behavioral changes

[Advanced AD]


• Oxidative stress

• Inflammation

• Microglial activation

• Neuronal loss

• Death

AD2

by noel

0
0 uses